CN1090947C - Patch powder composition and wet cloth preparation thereof - Google Patents
Patch powder composition and wet cloth preparation thereof Download PDFInfo
- Publication number
- CN1090947C CN1090947C CN96107101A CN96107101A CN1090947C CN 1090947 C CN1090947 C CN 1090947C CN 96107101 A CN96107101 A CN 96107101A CN 96107101 A CN96107101 A CN 96107101A CN 1090947 C CN1090947 C CN 1090947C
- Authority
- CN
- China
- Prior art keywords
- weight
- powder composition
- blood
- traditional chinese
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 239000000843 powder Substances 0.000 title claims abstract description 68
- 239000004744 fabric Substances 0.000 title claims description 18
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000003814 drug Substances 0.000 claims abstract description 33
- 239000000052 vinegar Substances 0.000 claims abstract description 21
- 235000021419 vinegar Nutrition 0.000 claims abstract description 21
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 18
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 17
- 244000203593 Piper nigrum Species 0.000 claims abstract description 16
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 16
- 240000007594 Oryza sativa Species 0.000 claims abstract description 15
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 15
- 235000009566 rice Nutrition 0.000 claims abstract description 15
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 14
- 229940010454 licorice Drugs 0.000 claims abstract description 14
- 235000013614 black pepper Nutrition 0.000 claims abstract description 13
- 239000001931 piper nigrum l. white Substances 0.000 claims abstract description 13
- 241000258920 Chilopoda Species 0.000 claims abstract description 12
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 12
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 12
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 10
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 9
- 230000017531 blood circulation Effects 0.000 claims abstract description 9
- 206010004542 Bezoar Diseases 0.000 claims abstract description 7
- 244000144725 Amygdalus communis Species 0.000 claims description 12
- 235000020224 almond Nutrition 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 240000000031 Achyranthes bidentata Species 0.000 claims description 11
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 9
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 5
- 241000270666 Testudines Species 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims 3
- 241000202807 Glycyrrhiza Species 0.000 claims 3
- 235000006533 astragalus Nutrition 0.000 claims 3
- 210000004233 talus Anatomy 0.000 claims 3
- 241001482311 Trionychidae Species 0.000 claims 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims 1
- 241000180649 Panax notoginseng Species 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 16
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract description 11
- 244000124209 Crocus sativus Species 0.000 abstract description 10
- 235000015655 Crocus sativus Nutrition 0.000 abstract description 10
- 239000004248 saffron Substances 0.000 abstract description 10
- 235000013974 saffron Nutrition 0.000 abstract description 10
- 239000003053 toxin Substances 0.000 abstract description 9
- 231100000765 toxin Toxicity 0.000 abstract description 9
- 235000014101 wine Nutrition 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 6
- 240000000073 Achillea millefolium Species 0.000 abstract description 4
- 235000007754 Achillea millefolium Nutrition 0.000 abstract description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract description 3
- 238000000227 grinding Methods 0.000 abstract description 2
- 241000241550 Cyathula Species 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 44
- 210000004369 blood Anatomy 0.000 description 44
- 210000002683 foot Anatomy 0.000 description 29
- 230000000694 effects Effects 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 230000036772 blood pressure Effects 0.000 description 12
- 239000011505 plaster Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 206010020772 Hypertension Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 238000001784 detoxification Methods 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 206010003210 Arteriosclerosis Diseases 0.000 description 9
- 208000011775 arteriosclerosis disease Diseases 0.000 description 9
- 206010019468 Hemiplegia Diseases 0.000 description 8
- -1 polyethylene Polymers 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 241000416162 Astragalus gummifer Species 0.000 description 7
- 229920001615 Tragacanth Polymers 0.000 description 7
- 235000010487 tragacanth Nutrition 0.000 description 7
- 239000000196 tragacanth Substances 0.000 description 7
- 229940116362 tragacanth Drugs 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000006011 Stroke Diseases 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 229940126680 traditional chinese medicines Drugs 0.000 description 6
- 241000373168 Glyptemys insculpta Species 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 230000003276 anti-hypertensive effect Effects 0.000 description 5
- 210000004207 dermis Anatomy 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000004745 nonwoven fabric Substances 0.000 description 5
- 230000003449 preventive effect Effects 0.000 description 5
- 208000017667 Chronic Disease Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 3
- 241000722941 Achillea Species 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 206010008132 Cerebral thrombosis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 235000016761 Piper aduncum Nutrition 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- 239000008575 shengdi Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 3
- 210000004026 tunica intima Anatomy 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 235000010407 ammonium alginate Nutrition 0.000 description 2
- 239000000728 ammonium alginate Substances 0.000 description 2
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 201000010603 frozen shoulder Diseases 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920001083 polybutene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000037922 refractory disease Diseases 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 235000019991 rice wine Nutrition 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPXKNYVSOKOLKD-BTJKTKAUSA-N (z)-but-2-enedioic acid;n-chloroaniline Chemical compound OC(=O)\C=C/C(O)=O.ClNC1=CC=CC=C1 FPXKNYVSOKOLKD-BTJKTKAUSA-N 0.000 description 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001528553 Malus asiatica Species 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Chemical class OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241000736816 Xanthorhiza Species 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical class C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229960003654 desoxycortone Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000005679 goldenseal Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Chemical class 0.000 description 1
- 150000002689 maleic acids Chemical class 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical class O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 1
- 239000001384 succinic acid Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Chemical class OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本发明涉及贴敷散组合物,尤指主要以选自由具有通血路功能的桃仁、南杏仁、白胡椒、糯米及白蓍而组成的物质组中选择的一种或一种以上中药原药材30~45重量%,及选自由具有排毒功能的地蜈蚣、西红花、金银花、大黄、牛黄、甘草粉、丹参、川芎、土鳖、牛膝及黄蓍而组成的物质组中选择的一种或一种以上中药原药材55~70重量%,与选自由具有软化角质层功能的醋、醋酸盐类、川七及生地而组成的物质组中选择的一种或一种以上物质(其量为前二者合计量之约0.5~4重量%),经予研碎,视需要时加入增粘剂,以醋、水或洒调匀成糊状,该由中药原药材配制的贴敷散剂型可供贴敷之用,其可贴敷于人体皮肤的特定部位或感受器官的相应部位,达到通经活络、扶正祛邪、行气活血的治病目的。The present invention relates to a sticking powder composition, especially one or more raw materials of traditional Chinese medicine selected from the group consisting of peach kernels, southern almonds, white pepper, glutinous rice and white yarrow, which have the function of opening blood passages. ~45% by weight, and one selected from the group consisting of centipede, saffron, honeysuckle, rhubarb, bezoar, licorice powder, salvia miltiorrhiza, Chuanxiong, wood turtle, achyranthes bidentata and tragacanth with detoxification function or 55% to 70% by weight of more than one raw material of traditional Chinese medicine, and one or more substances selected from the group consisting of vinegar, acetates, Chuanqi and Shengdi which have the function of softening the cuticle (the amount is The total amount of the first two is about 0.5-4% by weight), after being ground, adding a thickening agent if necessary, mixing it with vinegar, water or sprinkling into a paste, and the application powder prepared by the raw materials of traditional Chinese medicine is available For application, it can be applied to a specific part of the human skin or the corresponding part of the sensory organs to achieve the therapeutic purpose of dredging the meridian and activating collaterals, strengthening the body and eliminating pathogenic factors, and promoting qi and blood circulation.
一般中、老年人随着年龄的增长,体力、气力及生理功能逐渐衰减退化,对外来病毒的抵抗能力减弱,对突变的气候环境的适应能力亦不如往前,如何使中、老年人提高抗病能力,适应水土的突变,即为目前中、老年人保健的主要任务。虽然世界各国医药界均朝此方向努力,并研究开发化学医药产品,所用的药方有单方、复方,剂型亦有冲剂、针剂、片剂等等,然而其合成制造上甚为繁复,且常伴有副作用,并伤及胃肠及肝脏,因而仍不甚理想。Generally, as the middle-aged and elderly people grow older, their physical strength, vigor and physiological functions gradually decline and degenerate, their resistance to foreign viruses weakens, and their ability to adapt to sudden changes in climate and environment is not as good as before. How to improve the resistance of middle-aged and elderly people? Disease ability and adaptation to sudden changes in water and soil are the main tasks of health care for middle-aged and elderly people. Although the medical circles all over the world are making efforts in this direction and researching and developing chemical pharmaceutical products, the prescriptions used include single prescriptions and compound prescriptions, and the dosage forms include granules, injections, tablets, etc. However, their synthesis and production are very complicated and often accompanied by There are side effects, and damage to the gastrointestinal tract and liver, so it is still not ideal.
尤其动脉硬化为人体老化过程中最常发生的病症之一,随着年龄的增长,中老年人当中动脉硬化的发病率越高,而通常先有主动脉硬化、冠状动脉硬化,而后发生脑动脉硬化。如果合并高血压则更是造成脑出血及脑血栓形成的危险因素。经医学研究调查结果显示,动脉硬化是老年人死亡的主要原因,心血管病、脑血管病占死亡人数第一位,其主要由动脉硬化所造成的。因此人们从中获得启示:欲减少中风半身不遂,即须先预防动脉硬化的发生与发展,防止动脉硬化即须从降低血脂的总量着手。高血脂亦系导致动脉硬化性心脏病的危险因素。如何降低高血脂,不仅能预防中风半身不遂,并且可延年益寿。研究人员又研究调查显示,发生半身不遂,基本上由高血压及动脉硬化二种原因引起,其中高血压占半身不遂发病率的80%,常见于老年患者中。高血压象一种长期慢性病症,常常引起动脉硬化,其原因在于高血压会使血管张力增加、动脉内膜过度紧张、弹力纤维发生破裂、动脉内膜受损、影响血管的通透性及养分的输送。高血压又容易引起毛细血管破裂,动脉内膜出血形成血块。如此由于血液成分的改变,促使血液中的胆固醇、甘油三脂的增高,造成动脉硬化。In particular, arteriosclerosis is one of the most common diseases in the aging process of the human body. With the increase of age, the incidence of arteriosclerosis among middle-aged and elderly people is higher. Usually, aortic sclerosis and coronary arteriosclerosis occur first, and then cerebral arteriosclerosis occurs. hardening. If combined with high blood pressure, it is a risk factor for cerebral hemorrhage and cerebral thrombosis. According to medical research and investigation results, arteriosclerosis is the main cause of death in the elderly, and cardiovascular disease and cerebrovascular disease account for the first number of deaths, which are mainly caused by arteriosclerosis. Therefore, people get enlightenment from it: in order to reduce hemiplegia caused by apoplexy, the occurrence and development of arteriosclerosis must be prevented first, and the prevention of arteriosclerosis must start with reducing the total amount of blood lipids. Hyperlipidemia is also a risk factor for atherosclerotic heart disease. How to reduce hyperlipidemia can not only prevent stroke and hemiplegia, but also prolong life. Researchers have also studied and investigated, and hemiplegia is basically caused by two reasons: hypertension and arteriosclerosis. Among them, hypertension accounts for 80% of the incidence of hemiplegia, which is common in elderly patients. Hypertension, like a long-term chronic disease, often causes arteriosclerosis. The reason is that high blood pressure increases vascular tension, excessive tension in the arterial intima, rupture of elastic fibers, damage to the arterial intima, and affects the permeability and nutrients of blood vessels. delivery. High blood pressure can easily cause capillary rupture and arterial intima hemorrhage to form blood clots. In this way, due to the change of blood components, the cholesterol and triglycerides in the blood will increase, resulting in arteriosclerosis.
患有高血压病时,由于血管壁的增厚及血中脂质相互作用,会产生动脉壁脂质淀积,使动脉壁增厚、变硬、变脆、弹性消失,当血压突然升高而已有病变的动脉壁不能再承受时,动脉壁即发生破裂而出血。发生在脑血管时称作脑出血。高血压病人未经妥善治疗,最容易发生脑中风,以至半身不遂。When suffering from hypertension, due to the thickening of the blood vessel wall and the interaction of lipids in the blood, there will be lipid deposition on the arterial wall, which will thicken, harden, become brittle, and lose elasticity. When the blood pressure suddenly rises When the arterial wall with existing disease can no longer bear it, the arterial wall ruptures and bleeds. When it occurs in a blood vessel in the brain it is called a cerebral hemorrhage. Without proper treatment, hypertensive patients are most prone to stroke and even hemiplegia.
至于平时有高血压或脑动脉硬化或血液流变学异常,常有头晕、目眩及拇指、食指麻木的现象,如何洞察这些现象即成为目前医疗界努力研究开发的目标。中医指出常吃高脂肪食物的肥胖人容易患半身不遂,气虚血瘀即是发生半身不遂的重要原因,亦有认为系气血俱虚、经络堵塞而引起的。As for high blood pressure, cerebral arteriosclerosis, abnormal blood rheology, dizziness, dizziness, and numbness of the thumb and index finger, how to understand these phenomena has become the goal of research and development in the medical field. Traditional Chinese medicine points out that obese people who often eat high-fat food are prone to hemiplegia. Qi deficiency and blood stasis are the important causes of hemiplegia, and some people think that it is caused by deficiency of qi and blood and blockage of meridians.
然而针对上述病症的治疗,药剂的合成、制剂过程甚为繁复,且在用药上常有副作用,结果会伤及胃肠及肝脏,因而亦不甚理想。However, for the treatment of the above-mentioned diseases, the synthesis and preparation process of the medicament is very complicated, and there are often side effects in the medication, which will damage the gastrointestinal tract and liver as a result, so it is not ideal.
本发明人有鉴于此,以亲身经历的半身不遂经验对脑血栓引起的中风,在开刀去除有生命危险情况下,涉猎古文记载及对安全性较高的贴敷方式认同的基础上,根据中医、中药理论为中、老年人研制出预防中风、心血栓病变、降低胆固醇、疏通经络(治筋骨酸痛),消除体内毒素、解劳祛烦,根除青春豆、香港脚、妇女月经不顺、手脚麻痹、肩周炎等病症的贴敷散组合物。In view of this, the present inventor, on the basis of personal experience of hemiplegia, on the basis of the stroke caused by cerebral thrombosis, under the situation of life-threatening surgical removal, dabbled in ancient Chinese records and agreed with the higher security sticking method, according to traditional Chinese medicine, The theory of traditional Chinese medicine has been developed for middle-aged and elderly people to prevent stroke, heart thrombosis, lower cholesterol, dredge meridians (treat muscle and bone pain), eliminate toxins in the body, relieve labor and troubles, eradicate youth beans, Hong Kong's feet, women's menstrual irregularities, and numbness of hands and feet. , Frozen shoulder and other diseases of sticking powder composition.
上述各种病症其实归根究底,均系互为表里,为气虚血瘀、经络堵塞所致,而使体内病毒聚集,诱发病灶的产生。若能以贴敷散组合物不经口服而经真皮吸收至人体来传递药效,可避免口服药物对胃肠及肝脏的损伤,可说是方法简单、安全稳妥,疗效确切,应不失为一可行方式。In fact, the above-mentioned various diseases are all external and internal, which are caused by qi deficiency and blood stasis, and blockage of meridians, which makes viruses in the body gather and induces the generation of lesions. If the Tie Shi powder composition can be absorbed into the human body through the dermis without oral administration to deliver the drug effect, it can avoid the damage to the gastrointestinal tract and liver caused by the oral drug. Way.
此种以贴敷散组合物经调合成糊状贴敷于人体皮肤的特定部位或感受器官的相应部位的外敷治疗方法,可说是治疗常见病、慢性病、多发病、难治性疾病的重要方法。This kind of external application treatment method, in which the sticking powder composition is blended into a paste and applied to a specific part of the human skin or the corresponding part of the receptor, can be said to be an important method for treating common diseases, chronic diseases, frequently-occurring diseases, and refractory diseases. method.
上述贴敷疗法可以上病上贴、下病上敷,内病外贴,病处敷药。古人早已常用贴敷疗法治病取得疗效。如李时珍在本草纲目一书中述及“生附子研末和以葱汁为泥,贴敷涌泉穴治疗鼻渊病”,此均说明贴敷疗法属流传已久的疗法。The above-mentioned sticking therapy can be applied on the upper disease, upper application on the lower disease, external application on the internal disease, and application of medicine on the diseased part. The ancients have long used sticking therapy to treat diseases and achieve curative effect. For example, Li Shizhen mentioned in the book "Compendium of Materia Medica" that "the raw aconite is ground into powder and green onion juice is used as mud, and sticking to Yongquan point is used to treat nasal sinusitis", which shows that sticking therapy is a long-standing therapy.
至于治疗部位何以选用在人体皮肤的特定部位或感受器官的相应部位上。通常如众所周知的目前曾盛行的吴神父脚底按摩方式,因以脚底分布有相对应人体感受器官的相应穴道,虽其具有一定疗效,然其终究系一物理按摩方式,仅具短暂纾解的作用并末真正有疗效。As for why the treatment site is selected on the specific site of the human skin or the corresponding site of the receptor. Generally, as the well-known and popular foot massage method of Father Wu, because there are corresponding acupoints on the soles of the feet corresponding to the receptors of the human body, although it has a certain curative effect, it is a physical massage method after all, and it only has a short-term relief effect. Not really curative.
而本发明以应用中药原药材经调配研磨成粉末配制的贴敷散剂型,此贴敷散组合物调和成糊状贴敷在人体皮肤的特定部位或感受器官的相应部位,即为在该治疗部位上,贴敷散组合物可透过皮肤的毛孔,容易由真皮吸收至人体内,因真皮90%系血管丰富的结缔组织,可担负传递药物的作用。在此治疗部位上百会穴毛囊数目多,通透性高,极有利于药物的吸收,且手足角质层薄,为药物极容易吸收的部位,故贴敷散组合物可通过穴位、皮毛、经脉而起作用,从而达到通经活络、行气活血的治病目的。此系因穴位分布在经络上,经络为人体组织结构的重要组成部分,为沟通表里上下的一独特系统,其外与皮肤肌腠相接,内与五脏六腑相连,用药贴敷在穴位上,刺激穴位发挥传导经络的作用,使药物能充分发挥药理作用。由前述可知若用贴敷散组合物,可不经口服(或针剂),而经真皮吸收至人体,传递药效可避免口服药物对胃肠及肝脏的损伤,可说是方法简单、安全稳妥、疗效确切的可行方法,是治疗常见病、慢性病、多发病、难治疾病的重要方法。However, the present invention uses the raw materials of traditional Chinese medicines and grinds them into powder for application. On the site, the sticking powder composition can penetrate the pores of the skin and be easily absorbed into the human body from the dermis, because 90% of the dermis is a connective tissue rich in blood vessels, which can be responsible for the delivery of drugs. The number of hair follicles on the Baihui acupoint on the treatment site is large and the permeability is high, which is very conducive to the absorption of the drug, and the cuticle of the hands and feet is thin, which is the site where the drug is easily absorbed. Therefore, the sticking powder composition can pass through the acupuncture points, fur, Meridians work, so as to achieve the purpose of treating diseases by dredging the meridians, activating collaterals, promoting qi and blood circulation. This is because the acupuncture points are distributed on the meridian, which is an important part of the human tissue structure. It is a unique system that communicates the inside and outside. , stimulating the acupoints to play the role of conducting meridians, so that the drug can fully exert its pharmacological effects. It can be seen from the above that if the sticking powder composition is used, it can be absorbed into the human body through the dermis without oral administration (or injection), and the delivery of the drug effect can avoid the damage to the gastrointestinal tract and liver of the oral drug. It can be said that the method is simple, safe and reliable. A feasible method with definite curative effect is an important method for treating common diseases, chronic diseases, frequently-occurring diseases, and refractory diseases.
至于如何配制贴敷散组合物,此经本发明人钻研中医药书及各家百氏处方书,在具有通经活络、扶正祛邪、行气活血以化瘀的中药基础上整理筛选而成。As for how to prepare the Tie Shi San composition, the inventor studied Chinese medicine books and various Baishi prescription books, sorted out and screened on the basis of traditional Chinese medicines that have the functions of dredging the meridian and activating collaterals, strengthening the body and eliminating pathogenic factors, promoting qi and blood circulation to remove blood stasis. .
至于具有通经络、扶正祛邪、行气活血化瘀的中药经予筛选,计有:桃仁:其药性作用为祛瘀破血、润燥滑肠,适应于血瘀As for the traditional Chinese medicines that can dredge the meridians, strengthen the body and eliminate pathogenic factors, promote qi, activate blood and remove blood stasis, after screening, there are: peach kernel: its medicinal effect is to remove blood stasis and break blood, moisten dryness and smooth intestines, and is suitable for blood stasis.
痛经、闭经、跌打损伤;糯米:可解毒化脓,另经研磨成粉,有粘性,适于调合Dysmenorrhea, amenorrhea, bruises; glutinous rice: it can detoxify and suppurate, and it is ground into powder, which is sticky and suitable for blending
成糊状;白胡椒:具有下气消炎作用,亦用作引经,可配合桃仁、into a paste; White Pepper: It has the effect of lowering the Qi and reducing inflammation, and is also used for citing scriptures. It can be combined with peach kernels,
西红花的祛瘀破血作用,使毒素排出;杏仁:可降气行痰,能发汗,与桂子、胡椒一起均具有Saffron has the function of dispelling blood stasis and breaking blood, and expels toxins; almond: it can lower Qi and promote phlegm, and can sweat.
引经作用,配合桃仁、(西)红花的破瘀血、消 The effect of citing scriptures, combined with peach kernels and (West) safflower to break blood stasis and eliminate
肿并有导引、降气行痰,且将毒气化为汗液排出Swelling with guidance, lowering qi and promoting phlegm, and turning poisonous gas into sweat to expel
体外的作用。Effects in vitro.
上述成分中的桃仁、糯米、胡椒等三种成分已见之于高允旺编著的《大陆偏方治大病-下册》(旺安出版社,台湾区初版:1992年7月15日,第四页)一书的降压饼偏方的组成中,惟其仅系具通血路的功能,并达到降血压的部分疗效,然而对各该成分的用量末见详细记载。本发明人除为达到具有通血路功能外,另经苦心钻研中药配方,整理并选择采用具有排毒功能的中药原药材,且为软化脚底贴敷部位的角质层而另采用诸如醋及醋酸盐类、蛋白、生地、川七,以酒、水或醋等可将贴敷散组合物调匀成糊状供贴敷之用的软化剂。Among the above-mentioned ingredients, peach kernels, glutinous rice, and pepper have been found in "Mainland Folk Remedies for Serious Illnesses-Volume 2" edited by Gao Yunwang (Wang'an Publishing House, first edition in Taiwan: July 15, 1992, page 4) In the composition of the antihypertensive cake folk prescription in the book, it only has the function of dredging the blood and achieves a partial effect of lowering blood pressure. However, the dosage of each component is not recorded in detail. In addition to achieving the function of blood circulation, the inventor has painstakingly studied the formula of traditional Chinese medicine, sorted out and selected the raw materials of traditional Chinese medicine with detoxification function, and used other substances such as vinegar and acetate to soften the cuticle of the sole of the foot. , egg white, raw land, Chuanqi, wine, water or vinegar, etc. can be used to mix the sticking powder composition into a paste for sticking softener.
除以上贴敷散组合物的达到通血路功能组成成分外,只要具有益气、活血续血生新、祛痰通脉、开窃益智的具有排毒功能的原药材均可入药成贴敷散组合物的组成成分,例如可列举出西红花、大黄、丹参、川芎、土鳖、牛膝、黄蓍等。若予加入本发明的贴敷散组合物中,其用量占组合物全量之约20~60重量%。至于各别药味的作用,以黄蓍为例,其药理作用具补气升阳、固表止汗、利水消肿、排脓,并对血压有双调节作用、血压高时可降压,血压低时可升压,常用可活血而不伤正气、阴阳得平、气血得和,在活血化瘀上深具疗效。In addition to the components of the above Tie Shi San compositions that achieve the function of dredging blood, as long as the original medicinal materials with detoxification function can be used as Tie Shi San The components of the composition include, for example, saffron, rhubarb, salvia miltiorrhiza, Chuanxiong, wood turtle, achyranthes bidentata, and tragacanth. If it is added to the patch powder composition of the present invention, its consumption accounts for about 20-60% by weight of the total amount of the composition. As for the effects of different medicinal flavors, take tragacanth as an example. Its pharmacological effects have the functions of invigorating qi and raising yang, strengthening the surface and antiperspirant, diuresis, reducing swelling, and draining pus. It also has dual regulating effects on blood pressure. When blood pressure is high, it can lower blood pressure. When it is low, it can increase blood pressure. It is often used to promote blood circulation without harming righteousness, balance yin and yang, and harmonize qi and blood. It has a deep effect on promoting blood circulation and removing blood stasis.
另外成分的药理作用,则分述如下:(西)红花:其功用主治破瘀血、消肿、止痛、生新血;丹参:系补血活血药,具有扩张血管,对改善瘀血症The pharmacological effects of other ingredients are described as follows: (West) safflower: its functions are mainly used to relieve blood stasis, reduce swelling, relieve pain, and generate new blood;
的循环障碍有明显的促进作用。The circulatory disorder has obvious promoting effect.
通常可用于本发明的贴敷散组合物中的具有排毒功能的组成成分,适用作引药成分,其可包括东洋参、甘草、金银花、倒地蜈蚣等,其中甘草在益气、解毒诸药方中常受重用,药效明显,故本发明的贴敷散组合物中亦可掺用之。金银花可散热解毒、治瘫疽疥癣,养血止渴,亦不失为可用的药材。以上供作引药的全部用量占贴敷散组合物的约30重量%。另外甘草可加入约1~10重量%,使引药的全量占贴敷散组合物约40重量%。各药味的掺加量视其药理作用的需要,可加减斟酌使用。The components with detoxification function that can be generally used in the sticking powder composition of the present invention are suitable as ingredients for priming medicines, which can include American ginseng, licorice, honeysuckle, centipede, etc., wherein licorice is used in various prescriptions for nourishing qi and detoxification. It is often reused in Chinese medicine and has obvious drug effects, so it can also be blended in the plaster powder composition of the present invention. Honeysuckle can dissipate heat and detoxify, treat paralysis, gangrene and scabies, nourish blood and quench thirst, and it is also an available medicinal material. The above total consumption for serving as priming medicine accounts for about 30% by weight of the plaster powder composition. In addition, about 1-10% by weight of licorice can be added, so that the total amount of the priming medicine accounts for about 40% by weight of the plaster powder composition. The dosage of each herbal flavor can be added or subtracted depending on the needs of its pharmacological effects.
本发明的贴敷散组合物的目的之一在于提供可选择采用除具有通血路功能的桃仁、南杏仁、白胡椒、糯米及白蓍而组成的物质组中选择的一种或一种以上中药原药材30~45重量%,另选择具有排毒功能的地蜈蚣、西红花、金银花、大黄、牛黄、甘草粉、丹参、川芎、土鳖、牛膝、黄蓍而组成的物质组中选择的一种或一种以上中药原药材55~70重量%,与选自由具有软化角质层的功能的醋及醋酸盐类、生地、川七组成的物质组中选择的一种或一种以上的物质,经于研碎,视需要时加入增粘剂后,以醋、水或酒调匀成糊状的由中药原药材配制的贴敷散剂型组合物,可供贴敷之用。One of the purposes of the sticking powder composition of the present invention is to provide one or more traditional Chinese medicines selected from the material group consisting of peach kernels, southern almonds, white pepper, glutinous rice and white yarrow, which have the function of opening blood passages. 30% to 45% by weight of the original medicinal material, and one selected from the material group composed of centipede, saffron, honeysuckle, rhubarb, bezoar, licorice powder, salvia miltiorrhiza, Chuanxiong, wood turtle, achyranthes bidentata, and tragacanth with detoxification function 55% to 70% by weight of one or more kinds of traditional Chinese medicine raw materials, and one or more substances selected from the group consisting of vinegar and acetates with the function of softening the cuticle, Shengdi and Chuanqi, After grinding, if necessary, adding a thickening agent, and mixing thoroughly with vinegar, water or wine, it is a powder-type composition for application prepared from raw materials of traditional Chinese medicines, which can be used for application.
如前述的《大陆偏方治大病-下册》第四页的降压饼偏方(包括白胡椒、杏仁、糯米、桃仁、山栀子)的组成成分,仅系具有通血路的功效,及达到降血压的部分疗效,加以“此偏方经研成细末,用鸡蛋清调和成饼状,贴敷在足心,以纱布包好,次日起床后,将药去除,若脚底发现青色,则表示血压降低。连续使用五天为一疗程”(摘自同页下半段)。如此发现此偏方仅具有通血路,达到降血压的部分疗效,但于贴敷后有脚底(板)呈现青紫色,有碍美观,尤其女子穿着高跟鞋时即有此种顾虑。加之在将敷药去除清洗后,脚底部出现青紫色,虽然前述偏方发挥药效将体内毒素吸引出体外,而于脚底板涂敷有此降压饼偏方的界面脚底肌肤处聚积并成紫青色。但脚部皮肤上出现少许红色小水泡(此现象类似人体脚趾间的香港脚水泡),此小水泡系体内毒素,经血液输送至脚趾末梢神经。若末梢神经可发挥功用时,则此毒素化成水泡,自脚底排出,若未能发挥功用时,则可由糖尿病、高血压病等慢性病患者因体内毒素未经此管道排泄,而有从足部脚底引起病痛的现象。As mentioned above, the antihypertensive biscuit formula (including white pepper, almond, glutinous rice, peach kernel, and gardenia) on the fourth page of "Mainland Folk Remedies for Serious Illnesses - Volume 2" only has the effect of dredging the blood, and can reduce the blood pressure. Part of the curative effect of blood pressure, plus "this folk prescription is ground into fine powder, mixed with egg white into a cake shape, applied on the center of the foot, wrapped with gauze, and removed after getting up the next day. If the sole of the foot is blue, it means Lower blood pressure. Continuous use for five days is a course of treatment" (from the second half of the same page). In this way, it was found that this folk prescription only has the effect of dredging the blood and lowering blood pressure. However, after the application, the soles (plates) of the feet turn purple, which is unsightly, especially when women wear high heels. In addition, after removing the dressing and cleaning it, the soles of the feet appeared blue and purple. Although the above-mentioned folk prescriptions exerted their medicinal effects to draw toxins out of the body, the skin on the soles of the soles of the feet where the prescription of the antihypertensive cake was applied accumulated and turned purple. . However, a few small red blisters appear on the skin of the feet (this phenomenon is similar to the blisters between the toes of the human body). These small blisters are endotoxins, which are transported to the peripheral nerves of the toes through the blood. If the peripheral nerves can function, the toxin will turn into blisters and be discharged from the soles of the feet. If it fails to function, it can be caused by the toxins in the body of patients with chronic diseases such as diabetes and hypertension without being excreted through this channel. Symptoms of illness.
有鉴于此,本发明的贴敷散组合物乃除选择采用具有通血路功能的中药原药材外,另选择采用具有排毒功能的中药原药材,及选用具有软化脚底角质层(俗称脚茧)功能的醋及醋酸盐类、生地、川七而组成的物质组中选择的一种或一种以上物质,经予调匀,视需要时加入增粘剂,以醋、水或酒调成糊状,这种由中药原药材配制的贴敷散组合物剂型可供贴敷之用。In view of this, the plaster powder composition of the present invention is not only selected to use the original Chinese medicinal materials with the function of dredging the blood, but also selected the original Chinese medicinal materials with the function of detoxification, and the function of softening the cuticle of the soles of the feet (commonly known as foot cocoons). One or more substances selected from the substance group consisting of vinegar and acetates, raw land, and Chuanqi, are thoroughly mixed, and thickeners are added if necessary, and vinegar, water or wine are used to make a paste. The dosage form of the sticking powder composition prepared from the raw materials of traditional Chinese medicines can be used for sticking.
为完全排除体内毒素,经发明人锐意钻研中医书籍,发现有地蜈蚣、西红花、金银花、大黄、牛黄、甘草粉、丹参、川芎、土鳖、牛膝、黄蓍等,经采用这些具有排毒功能的原药材,另由选用具有软化角质层功能的软化剂,例如醋及醋酸盐类、生地及川七,以醋、酒及水等,配合使用在软化角质层的同时,可促进贴敷散组合物的通血路功能,并使体内毒素排除顺畅,达到加倍的效果,且本发明的贴敷散组合物可不必如前述降压饼偏方的须以鸡蛋清调成饼状敷用那样的费事,亦无贴敷后于脚部形成青紫色的有碍观瞻的顾虑。In order to completely eliminate toxins in the body, the inventor studied the books of traditional Chinese medicine and found that there are centipede, saffron, honeysuckle, rhubarb, bezoar, licorice powder, salvia miltiorrhiza, Chuanxiong, ground turtle, achyranthes bidentata, tragacanth, etc., which have the functions of detoxification. Functional raw medicinal materials, in addition, choose softeners that have the function of softening the cuticle, such as vinegar and acetate, Shengdi and Chuanqi, vinegar, wine and water, etc., when used together to soften the cuticle, it can promote sticking powder The composition has the function of clearing the blood, and can remove toxins in the body smoothly, achieving a double effect, and the sticking powder composition of the present invention does not need to be as troublesome as the aforementioned antihypertensive cake prescription, which must be made into a cake shape with egg whites. , and there is no unsightly concern of blue-purple formation on the feet after application.
至于本发明的贴敷散组合物,除前述的桃仁、糯米及胡椒等三种成分的作用外,并末对用量有进一步说明。在此,本发明进一步对贴敷散的具有通血路、排毒及软化质层功能的组成及用量,予以说明如下:桃仁:作用如前所述。其用量约为10~30重量%,As for the sticking powder composition of the present invention, except for the effects of the aforementioned three ingredients such as peach kernel, glutinous rice and pepper, there is no further explanation on the dosage. Here, the present invention further explains the composition and dosage of Tie Shi San, which has the functions of blood circulation, detoxification and softening of the tissue layer, as follows: peach kernel: the effect is as described above. Its dosage is about 10-30% by weight,
在10重量%以下对祛瘀破血的功效较不显著;(西)花红:其功用主治破瘀血、消毒、止痛、生新血。Below 10% by weight, the effect on dispelling blood stasis and breaking blood is less significant; (West) Huahong: Its function is mainly for breaking blood stasis, disinfection, pain relief, and generating new blood.
其用量约为3~15重量%;糯米:作用如前所述。用量约为0.4~1.2重量%;白)胡椒:作用如前所述。用量约为0.4~1.2Its dosage is about 3 to 15% by weight; glutinous rice: the effect is as described above. The dosage is about 0.4 to 1.2% by weight; white) pepper: the effect is as mentioned above. The dosage is about 0.4~1.2
重量%;南杏仁:作用如前所述。其用量在配合桂枝、白胡椒时,% by weight; southern almond: the effect is as described above. When its dosage is combined with cinnamon sticks and white pepper,
以全量占贴敷散组合物之约10~30重量%, account for about 10 to 30% by weight of the plaster powder composition in full amount,
与桃仁合并使用时占组合物的约25重量%以When used in combination with peach kernels, it accounts for more than about 25% by weight of the composition
上。醋及醋酸盐类:通常醋系以食用醋为主。其用以软化脚 superior. Vinegar and acetates: Usually vinegar is mainly edible vinegar. its used to soften the feet
底角质层(茧),使体内排毒顺畅并加 The stratum corneum (cocoon) smoothes the detoxification in the body and increases
速通经络。醋主要为醋酸成分,通常为 Speed through the meridians. Vinegar is mainly composed of acetic acid, usually
液态。为使适用于本发明的贴敷散组合in liquid form. In order to make the patch suitable for the present invention combine
物,亦可采用醋酸的盐类,诸如醋酸钠、Substances, salts of acetic acid can also be used, such as sodium acetate,
醋酸钾、醋酸钙等。该醋酸盐类为粉末 Potassium acetate, calcium acetate, etc. The acetates are powdered
状固体,可掺用于贴敷散组合物内,在 Like solids, which can be mixed into powder compositions for application, in
使用之际,以水或其他液体(如:酒) When in use, use water or other liquids (such as: wine)
调匀成糊状,供贴敷即可;增粘剂:前述降压饼偏方在使用前,以鸡蛋清调成饼状 Mix thoroughly to form a paste, ready for application; thickener: before using the above-mentioned antihypertensive biscuit formula, mix it with egg whites to form a cake
方可贴敷,使用起来麻烦费事。本发明的贴敷It can only be applied, and it is troublesome to use. Application of the present invention
散组合物可在组合物中事先加约0.5~2.The bulk composition can be added in advance about 0.5 to 2.
0重量%的增粘剂干燥粉末。适用的增粘剂,0% by weight tackifier dry powder. Suitable tackifiers,
可列举出的有:聚丙烯酸钠、聚丙烯酸、聚乙 Can be listed: sodium polyacrylate, polyacrylic acid, polyethylene
烯醇、聚乙烯基。吡咯啶酮类的合成水溶性高Enol, polyvinyl. Synthesis of pyrrolidones with high water solubility
分子,阿拉伯胶、淀粉、蛋白、明胶等天然高Molecules, natural high content such as gum arabic, starch, protein, gelatin, etc.
分子、甲基纤维素、羟丙基纤维素、羧甲基纤Molecule, methylcellulose, hydroxypropylcellulose, carboxymethylcellulose
维素钠、藻酸、藻酸钠、藻酸铵等;酒类:一般供贴敷散组合物用者为米酒,而其他酒类视Sodium vitamins, alginic acid, sodium alginate, ammonium alginate, etc.; wine: rice wine is generally used for plaster powder compositions, while other wines are regarded as
需要亦可适用,其作用除调合用外,亦可加速药 It can also be applied if necessary. Its function can not only be used for blending, but also can accelerate the speed of medicine.
效的通经络(消瘀通脉)。Effective dredging of the meridians (removing blood stasis and dredging the veins).
本发明的贴敷散组合物,可配制成贴敷散剂型,以不经口服,而经由真皮吸收至人体,传递药效,可避免口服药物的对胃肠及肝脏的损伤,可以说是方法简单、安全稳妥、疗效确切,应不失一可行方式。其主要以选自由具有通血路功能的桃仁、南杏仁、白胡椒、糯米及白蓍所组成的物质组中选择的一种或一种以上中药原药材30~45重量%,及选自由具有排毒功能的地蜈蚣、西红花、金银花、大黄、牛黄、甘草粉、丹参、川芎、土鳖、牛膝及黄著而组成的物质组中选择的一种或一种以上中药原药材55~70重量%,与选自由具有软化角质层功能的醋及醋酸盐类、川七及生地而组成的物质组中选择的一种或一种以上物质0.5~4.0重量%(以前二者合计量计)经予研碎,视需要时加入增粘剂,以醋、水或酒调匀成糊状可供贴敷之用。The sticking powder composition of the present invention can be formulated into a sticking powder, so that it can be absorbed into the human body through the dermis without taking it orally, so as to deliver the drug effect and avoid the damage to the gastrointestinal tract and liver caused by the oral medicine. It can be said to be a method. Simple, safe and reliable, with definite curative effect, it should be a feasible method. It mainly contains 30-45% by weight of one or more raw materials of traditional Chinese medicine selected from the group consisting of peach kernels, southern almonds, white pepper, glutinous rice and white yarrow, and selected from the One or more raw materials of traditional Chinese medicine selected from the material group consisting of centipede, saffron, honeysuckle, rhubarb, bezoar, licorice powder, salvia miltiorrhiza, Chuanxiong, ground turtle, achyranthes bidentata, and Huangzhu 55-70 weight %, with one or more substances selected from the group consisting of vinegar and acetates with the function of softening the cuticle, Chuanqi and habitat, 0.5 to 4.0% by weight (the total amount of the former two) Grind it, add thickening agent if necessary, mix thoroughly with vinegar, water or wine to form a paste for sticking.
另外本发明的贴敷散组合物,可予配制成湿布剂,亦即本发明的贴敷散组合物可形成一种对皮肤施用贴敷的经皮治疗系统,此系统包括一个不渗透活性物质(此活性物质即贴敷散组合物经调匀后可供贴敷之用的组合物)的覆盖层、一个压力敏感的粘附贮层(如后述的湿布基剂)及一个视需要可有可无的可撕除的保护层,包含有一个织物或非织物被贴附于一个预制的自粘性湿布基剂上,将本发明的贴敷散组合物调匀成糊状,形成活性物质附着物被加到织物或无纺布上,其后对基剂及活性物质附着物被覆一覆盖层。此即配制成一般所谓的湿布剂。In addition, the plaster powder composition of the present invention can be pre-formulated into a wet cloth, that is, the plaster powder composition of the present invention can form a transdermal therapeutic system for skin application, and this system includes an impermeable active substance (this active substance is the composition that can be used for sticking after mixing the powder composition for application), a pressure-sensitive adhesive storage layer (such as the wet cloth base described later) and an optional The optional removable protective layer, comprising a woven or non-woven fabric is attached to a prefabricated self-adhesive wet cloth base, the patch powder composition of the present invention is mixed into a paste to form the active substance attachment It is added to the fabric or non-woven fabric, and then the base and the active substance attachment are covered with a covering layer. This is formulated into a so-called wet cloth.
下面对湿布剂加以说明。湿布剂系由选自由聚丙烯酸钠、聚丙烯酸、聚乙烯醇、聚乙烯基吡咯啶酮、聚环氧乙烷、聚乙烯基丙烯酸酯等的合成水溶性高分子、阿拉伯胶、淀粉、明胶等的天然物质、甲基纤维素、羟丙基纤维素、藻酸、藻酸钠、藻酸铵及羧甲基纤维素钠而组成的物质组中选择的一种或一种以上的增粘剂、选自由尿素、甘油、丙二醇、丁二醇及葡萄糖醇而组成的物质组中选择的一种或一种以上湿润剂、选自由高岭土、氧化锌、滑石粉、钛白粉、膨土及环氧树脂类而组成的物质组中选择的一种或一种以上填充剂,选自由柠檬酸、酒石酸、顺丁烯二酸、顺丁烯二酸酐及琥珀酸的钙、镁及铝盐而组成的物质组中选择的一种或一种以上有机酸盐、水,及选自由碳酸丙烯及已二酸二异丙酯而组成的物质组中选择的一种或一种以上溶解助剂及选自由松香脂、酯胶、聚丁烯及聚丙烯酸酯而组成的物质组中选择的一种或一种以上粘着赋予剂,及选自由顺丁烯二酸氯苯胺、甘草酸苷及副肾皮质而组成的物质组中选择的一种或一种以上接触皮肤炎防止剂,及视需要添加选自由水杨酸、水杨酸甲酯、水杨酸二醇、1-醇、樟脑、壬酸香草酰胺、瑞香酚、辣椒素及薄荷油而组成的物质组中选择的一种或一种以上添加剂配制成湿布基剂,将本发明的贴敷散组合物调匀成糊状,形成活性物质附着物加至湿布基剂并予加至织物或无纺布上,其后对基剂及活性物质附着物被覆一覆盖层即成本发明贴敷散组合物的湿布剂。The wet cloth agent will be described below. The wet cloth agent is composed of synthetic water-soluble polymers selected from sodium polyacrylate, polyacrylic acid, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene oxide, polyvinyl acrylate, etc., gum arabic, starch, gelatin, etc. One or more thickeners selected from the group consisting of natural substances, methylcellulose, hydroxypropylcellulose, alginic acid, sodium alginate, ammonium alginate and sodium carboxymethylcellulose , one or more wetting agents selected from the group consisting of urea, glycerin, propylene glycol, butylene glycol, and glucitol, selected from kaolin, zinc oxide, talc, titanium dioxide, bentonite, and epoxy One or more fillers selected from the group of substances consisting of resins, consisting of calcium, magnesium and aluminum salts of citric acid, tartaric acid, maleic acid, maleic anhydride and succinic acid One or more organic acid salts selected from the substance group, water, and one or more dissolution aids selected from the substance group consisting of propylene carbonate and diisopropyl adipate and selected from One or more adhesion-imparting agents selected from the group consisting of rosin resin, ester gum, polybutene and polyacrylate, and selected from the group consisting of chloroaniline maleate, glycyrrhizin and adrenal cortex One or more than one contact dermatitis preventive agent selected from the composition of the substance group, and if necessary, add the selected from salicylic acid, methyl salicylate, salicylic acid diol, 1-menth alcohol, camphor, nonanoic acid Vanillamide, Daphnetol, Capsaicin and Peppermint Oil are formulated with one or more additives selected from the material group to form a wet cloth base, and the paste powder composition of the present invention is thoroughly mixed into a paste to form an active substance attached The attachment is added to the wet cloth base and pre-added to the fabric or non-woven fabric, and then the base and the active substance attachment are coated with a covering layer, which is the wet cloth of the present invention.
另外,本发明的贴敷散组合物亦可配制成硬膏剂。硬膏剂用基剂为来自公知的高分子基剂(例如:;甲基丙烯酸酯类、丙烯腈、醋酸乙烯酯、丙酸乙烯酯等与乙烯基单体的共聚体的丙烯酸酯系组合物、硅氧树脂、聚异戊二烯橡胶、聚异丁烯橡胶、天然橡胶、丙烯酸酯系橡胶、苯乙烯-丁二烯-苯乙烯嵌段共聚体、苯乙烯-异戊二烯-苯乙烯嵌段共聚体等)、油脂或高级脂肪酸(例如:杏仁油、橄榄油、山茶花油、花生油、油酸油、石腊、聚丁烯等)、粘着赋予剂(例如:松香、松香改性顺丁烯二酸、加氢松香酯等)及接触皮肤炎防止剂经予适当选择采用,并于该基剂中视必要时加入如樟脑、1-醇、瑞香草酚、壬酸香草酰胺、辣椒素及薄荷油等其他添加剂配制成硬膏剂用基剂,将本发明的贴敷散组合物掺入基剂中可得均匀的混合物,将此混合物以一般的方法展延涂布于支持物(例如:为可伸缩性或非伸缩性的基布、无纺布或纸等而成硬膏剂)上,其上可贴合适当选用自聚乙烯、聚丙烯、聚氯乙烯、聚酯、聚偏二氯乙烯、硅氧加工纸等的剥离被覆物。In addition, the patch powder composition of the present invention can also be formulated into a plaster. The base for the plaster is derived from known polymer bases (for example: acrylate-based compositions of copolymers of methacrylates, acrylonitrile, vinyl acetate, vinyl propionate, etc., and vinyl monomers, Silicone resin, polyisoprene rubber, polyisobutylene rubber, natural rubber, acrylic rubber, styrene-butadiene-styrene block copolymer, styrene-isoprene-styrene block copolymer Body, etc.), oil or higher fatty acid (such as: almond oil, olive oil, camellia oil, peanut oil, oleic acid oil, paraffin, polybutene, etc.), adhesion imparting agent (such as: rosin, rosin modified maleic acid, hydrogenated abietate, etc.) and contact dermatitis preventive agents are appropriately selected, and if necessary, such as camphor, 1-menth alcohol, revanillol, nonanoic vanillyl amide, capsaicin and peppermint are added Other additives such as oil are formulated into the base for plaster, and the patch powder composition of the present invention is mixed in the base to obtain a uniform mixture, and this mixture is spread and coated on the support in a general way (for example: for Stretchable or non-stretchable base cloth, non-woven fabric or paper, etc.), on which it can be pasted appropriately from polyethylene, polypropylene, polyvinyl chloride, polyester, polyvinylidene chloride , Silicone processed paper, etc.
本发明的贴敷散组合物适用于高血压的降压、中风的预防,可使组合物中的成分发挥加倍疗效,其作用是将体内毒素引出体外,因为高血压、中风病患者常伴随形成脑血栓,使患者的血液流变行为异常,这已经专家、学者所证实。通常由全血粘度升高、血红素压积增高、血小板及血红素电泳时间延长、血纤维蛋白原升高、血小板聚集及粘附性增强等检查项目的异常可检验出。患者的血液在血液流变行为上异常,呈现“浓、粘、凝、聚”的血块。当然本发明的贴敷散组合物可对患者在预防治疗前后可分预防治疗组及对照组进行血液流变学变化比较(检查项目如上述可为全血粘度、血红素聚集指数、血红素压积、血纤维蛋白原、血小板聚集率、血小板粘附率)。通常预防治疗组可得具有降低血液粘稠度及血红素聚状态、降低血浆中纤维蛋白原及血小板聚集率与粘附率的作用的结果。而使用本发明贴敷散组合物者,可在使用前、后各滴其指头血液于水中,由水中血液凝聚的现象发现在使用后其血液滴入水中立即扩散,亦可容易得到证实血液粘稠度已降低。另由脚茧(角质层)变薄,光滑细腻,显然亦得知体内毒素由脚底排出。又本发明的贴敷散组合物对月经不顺(经痛)的妇女亦可适用,此由大量的乌黑瘀血排出体外的现象得到证实。The plaster powder composition of the present invention is suitable for reducing blood pressure of high blood pressure and preventing stroke, and can double the curative effect of the ingredients in the composition. Cerebral thrombosis makes the patient's blood rheology abnormal, which has been confirmed by experts and scholars. Usually, it can be detected by abnormalities in inspection items such as increased whole blood viscosity, increased hemoglobin, prolonged electrophoresis time of platelets and hemoglobin, increased fibrinogen, increased platelet aggregation and adhesion. The patient's blood is abnormal in hemorheological behavior, showing "thick, sticky, coagulated, and aggregated" blood clots. Of course, the sticking powder composition of the present invention can be divided into preventive treatment group and control group to carry out hemorheology change comparison to patient before and after preventive treatment (check items can be whole blood viscosity, hemoglobin aggregation index, hemoglobin pressure as mentioned above) volume, fibrinogen, platelet aggregation rate, platelet adhesion rate). Usually, the preventive treatment group can reduce blood viscosity and hemoglobin aggregation state, and reduce plasma fibrinogen and platelet aggregation rate and adhesion rate. And those who use the pasting powder composition of the present invention can drop blood from their fingers in water before and after use, and find that the blood coagulates in the water and immediately diffuses when it drops into the water after use, and it can also be easily confirmed that the blood is sticky. The consistency has been reduced. In addition, the callus (cuticle) of the foot becomes thinner, smoother and finer. Obviously, it is also known that toxins in the body are discharged from the sole of the foot. The sticking powder composition of the present invention is also applicable to women with irregular menstruation (dysmenorrhea), which is confirmed by the phenomenon that a large amount of jet-black stasis is excreted from the body.
以下用实施例进一步详细说明本发明的贴敷散组合物,惟此并非用以限制本发明的范围。以下实施例提及的重量%,系以贴敷散组合物全量计。The following examples are used to further describe the powder composition for application of the present invention in detail, but this is not intended to limit the scope of the present invention. The weight % mentioned in the following examples is based on the total amount of the patch powder composition.
实施例1Example 1
取桃仁16.0重量%、糯米0.8重量%、白胡椒1.0重量%、南杏仁12.0重量%、白蓍1.2重量%及地蜈蚣15.0重量%、西红花10.0重量%、金银花5.0重量%、大黄6.0重量%、甘草粉5.0重量%、丹参4.5重量%、川芎5.0重量%、土鳖7.0重量%、牛膝3.5重量%及黄蓍6.0重量%、醋酸钠2.0重量%经予辗压成粉末,于其中加入蛋白粉末3.0重量%(以前述全量计)。其后取所得粉末混合物100g,于其中徐徐加入水予以调匀成糊状、涂敷于脚底,以支持物(如可选自可伸缩或非伸缩性的基布、无纺布、非织物纸、聚乙烯、聚丙烯、聚氯乙烯、聚偏二氯乙烯、加工纸等)包覆并过夜(约8至10小时),拆除清洗贴敷散,发现脚底板角质层软化可予刮除,且脚底皮层细腻光滑,血压较施用前有下降现象。Take 16.0% by weight of peach kernel, 0.8% by weight of glutinous rice, 1.0% by weight of white pepper, 12.0% by weight of southern almond, 1.2% by weight of Achillea, 15.0% by weight of centipede, 10.0% by weight of saffron, 5.0% by weight of honeysuckle, and 6.0% by weight of rhubarb %, 5.0% by weight of licorice powder, 4.5% by weight of salvia miltiorrhiza, 5.0% by weight of Chuanxiong, 7.0% by weight of wood turtle, 3.5% by weight of Achyranthes bidentata, 6.0% by weight of tragacanth, and 2.0% by weight of sodium acetate. Protein powder 3.0% by weight (based on the aforementioned full amount). Then get the gained powder mixture 100g, slowly add water therein and mix thoroughly into a paste, apply to the soles of the feet, with support (such as can be selected from stretchable or non-stretchable base cloth, non-woven fabric, non-woven paper, Polyethylene, polypropylene, polyvinyl chloride, polyvinylidene chloride, processed paper, etc.) and leave it overnight (about 8 to 10 hours), remove the cleaning patch and apply it loosely, it is found that the cuticle of the sole of the foot is softened and can be scraped off, and The skin of the soles of the feet is delicate and smooth, and the blood pressure has decreased compared with before application.
实施例2Example 2
取桃仁14.0重量%、糯米1.0重量%、白胡椒1.0重量%、南杏仁18.0重量%、白蓍1.0重量%及地蜈蚣20.0重量%、西红花15.0重量%、甘草粉3.0重量%、丹参8.0重量%、川芎6.0重量%、土鳖2.0重量%、牛膝3.0重量%、黄蓍4.0重量%及川七4.0重量%经予辗压成粉末。其后取所得粉末混合物100g,于其中徐徐加入食用醋予以调匀成糊状,涂敷于脚底,以支持物包覆并过夜(约8至10小时)、拆除清洗贴敷散后,发现脚底板角质层软化可予刮除,且脚底皮肤细腻光滑,又妇女在经前有经痛现象,在贴敷后排出瘀黑经血,使月经顺畅。Take 14.0% by weight of peach kernel, 1.0% by weight of glutinous rice, 1.0% by weight of white pepper, 18.0% by weight of southern almond, 1.0% by weight of Achillea, 20.0% by weight of centipede, 15.0% by weight of saffron, 3.0% by weight of licorice powder, and 8.0% by weight of salvia miltiorrhiza % by weight, Rhizoma Chuanxiong 6.0% by weight, Eucalyptus 2.0% by weight, Achyranthes bidentata 3.0% by weight, Tragacanth 4.0% by weight and Chuanqi 4.0% by weight are rolled into powder. Then take 100g of the obtained powder mixture, slowly add edible vinegar to it, mix thoroughly to form a paste, apply it on the sole of the foot, cover it with a support and leave it overnight (about 8 to 10 hours), remove it, wash it, apply it loosely, and find the sole of the foot The cuticle softens and can be scraped off, and the skin on the soles of the feet is fine and smooth, and women have menstrual pain before menstruation. After the application, the black menstrual blood will be discharged to make menstruation smooth.
实施例3Example 3
取桃仁17.0重量%、糯米0.4重量%、白胡椒1.0重量%、南杏仁25.0重量%、白蓍0.6重量%及地蜈蚣8.0重量%、西红花7.0重量%、大黄9.0重量%、牛黄0.5重量%、甘草粉7.5重量%、丹参8.0重量%、川芎3.0重量%、土鳖5.0重量%、牛膝6.0重量%及黄著2.0重量%,经予辗压成粉末,于其中加入藻酸钠2.0重量%(以前述全量计)。其后取所得粉末混合物100g,于其中加入食用醋10.0ml及米酒予以调匀成糊状,涂敷于脚底,以支持物包覆并过夜(约8至10小时),拆除清洗贴敷散,发现脚底板角质层软化可予清洗,且脚底皮层细腻光滑,又对患有肩周炎病症者,在贴敷后不再有酸痛现象。Take 17.0% by weight of peach kernel, 0.4% by weight of glutinous rice, 1.0% by weight of white pepper, 25.0% by weight of southern almond, 0.6% by weight of Achillea, 8.0% by weight of centipede, 7.0% by weight of saffron, 9.0% by weight of rhubarb, and 0.5% by weight of bezoar %, 7.5% by weight of licorice powder, 8.0% by weight of salvia miltiorrhiza, 3.0% by weight of Rhizoma Chuanxiong, 5.0% by weight of wood turtle, 6.0% by weight of Achyranthes bidentata and 2.0% by weight of yellow root, which are rolled into powder, and 2.0% by weight of sodium alginate is added thereto % (based on the aforementioned full amount). Then take 100g of the obtained powder mixture, add 10.0ml of edible vinegar and rice wine to it, mix thoroughly to form a paste, apply it on the sole of the foot, cover it with a support and leave it overnight (about 8 to 10 hours), remove it, wash it and apply it loosely. The cuticle of the sole of the foot is softened and can be cleaned, and the skin of the sole of the foot is fine and smooth. For those suffering from frozen shoulder, there will be no soreness after application.
实施例4Example 4
取上述实施例的任一贴敷散组合物的粉末10-50重量%(以湿布剂的全量计)与已二酸异丙酯溶解辅助剂0.5~8重量%混合溶解成均匀状,其次将5~20重量%羧甲基纤维钠增粘剂分散溶解于5~40重量%甘油湿润剂及10~80重量%水内,添加10重量%氧化锌及滑石粉填充剂,使成均匀的混合物。将此混合物以一般方式展延涂布于支持物上,于其上经由贴附剥离被覆物可得湿布剂,可供贴敷脚底用。Get the powder 10-50% by weight (based on the total amount of the wet cloth preparation) of any sticking powder composition of the above-mentioned embodiment and mix and dissolve with 0.5-8% by weight of isopropyl adipate dissolution aid to form a uniform shape, and then 5-20% by weight of sodium carboxymethyl cellulose tackifier is dispersed and dissolved in 5-40% by weight of glycerin wetting agent and 10-80% by weight of water, and 10% by weight of zinc oxide and talc filler are added to make a uniform mixture . The mixture is spread and coated on the support in the usual way, and the covering can be peeled off on it to obtain a wet cloth preparation, which can be used for sticking the soles of the feet.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96107101A CN1090947C (en) | 1996-06-28 | 1996-06-28 | Patch powder composition and wet cloth preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96107101A CN1090947C (en) | 1996-06-28 | 1996-06-28 | Patch powder composition and wet cloth preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1169291A CN1169291A (en) | 1998-01-07 |
| CN1090947C true CN1090947C (en) | 2002-09-18 |
Family
ID=5119537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96107101A Expired - Lifetime CN1090947C (en) | 1996-06-28 | 1996-06-28 | Patch powder composition and wet cloth preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1090947C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110732037B (en) | 2018-07-20 | 2023-05-26 | 广州倍绣生物技术有限公司 | Hemostatic paste and preparation method thereof |
| CN120713981A (en) * | 2025-07-26 | 2025-09-30 | 西安交通大学医学院第一附属医院 | A traditional Chinese medicine composition for treating hypertension and its preparation method and application |
-
1996
- 1996-06-28 CN CN96107101A patent/CN1090947C/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| 浙江中医杂志1995,30(12) 1995.1.1 刘家磊 补气化瘀通络汤治疗中风208例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1169291A (en) | 1998-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU718457B2 (en) | Herb composition and an herbal plaster made from the same | |
| CN1255172C (en) | Medical paste for rheumatism and bone ache | |
| WO2008031322A1 (en) | Application of acetylcholine esterase inhibitor medication of leonurus extractive as cholinomimetic | |
| CN101085300A (en) | Plaster for treating hyperosteogeny and pain, and its preparation method | |
| CN1262299C (en) | Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method | |
| CN102274252B (en) | Stauntonvine external applied preparation for treating rheumatoid diseases and preparation method thereof | |
| CN1090947C (en) | Patch powder composition and wet cloth preparation thereof | |
| CN100998660B (en) | Traditional Chinese medicine patch for treating vertebral artery type cervical spondylosis and preparation method thereof | |
| CN104547251B (en) | A kind of navel patch and preparation method for treating chordapsus | |
| CN1739657A (en) | Chinese medicine naval plaster for laxation, reducing blood fat and slimming | |
| CN1310664C (en) | Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process | |
| CA2204210C (en) | Herb composition and an herbal plaster made from the same | |
| CN1833685A (en) | Chinese medicinal compsns. for treating burn and scald, its prepn. and usage | |
| CN111658716A (en) | Hydrogel magnetic therapy traditional Chinese medicine plaster and preparation method thereof | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN114504614B (en) | Traditional Chinese medicine composition for soft tissue injury, traditional Chinese medicine ointment and preparation method thereof | |
| CN1241614C (en) | Traumatic injury capsule and its manufacturing method | |
| CN109692324B (en) | It is a kind of to disappear the Chinese medicine hydrogel emplastrum and preparation method thereof of rouge for subtracting tripe | |
| CN1883529A (en) | A pharmaceutical composition for treating cardiovascular and cerebrovascular disease and preparation method thereof | |
| KR19980077402A (en) | Medicinal Herb Compositions and Medicinal Plaster Made Therefrom | |
| CN1209160C (en) | Chinese medicinal transdermal membrane agent for treating paralysis caused by central nerve injury and preparation method thereof | |
| CN1401356A (en) | Chinese medicine patch film and method for producing same | |
| CN104147230B (en) | A kind of External apply medicinal wine for the treatment of ischemic heart desease | |
| CN111481654A (en) | Composition for rapidly relieving pain and treating or preventing rennet pain and preparation medicine and method thereof | |
| CN117547568A (en) | A Chinese medicinal patch with effects of eliminating arthralgia and removing blood stasis, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20020918 |
|
| EXPY | Termination of patent right or utility model |